Rohto Pharmaceutical Co Ltd 2023 Integrated Report
Company: Rohto Pharmaceutical Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2023
Type: Integrated Report
Pages: 80
The report outlines Rohto's business performance and sustainability initiatives for the fiscal year ended March 31, 2023. The company achieved record-high net sales of 238.6 billion yen and operating income of 33.9 billion yen, driven by strong performance in its core skincare and eye care businesses. Key highlights include the launch of a new companion animal business, the opening of a smart plant building at the Ueno Techno Center, and the revision of its personnel system to promote employee well-being. Additionally, Rohto reduced its Scope 1 and 2 CO2 emissions by 17% compared to fiscal 2013 levels through solar power and carbon-free electricity.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.